Fatigue in Multiple Sclerosis

Physical Medicine and Rehabilitation Clinics of North America

Volumn 20, Issue 2, 2009, Pages 363-372

  Shah, Anjali ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Fatigue; Human; Multiple sclerosis; Neurorehabilitation; Quality of life; Treatment of fatigue

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ACETYLSALICYLIC ACID; AMANTADINE; ANTICONVULSIVE AGENT; FLUOXETINE; HISTAMINERGIC RECEPTOR AFFECTING AGENT; IBUPROFEN; INTERFERON; LEVACECARNINE; MODAFINIL; NAPROXEN; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; POTASSIUM CHANNEL BLOCKING AGENT; PROKARIN; SEDATIVE AGENT; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANKLE EDEMA; ANTIVIRAL ACTIVITY; ANXIETY; BELL PALSY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFUSION; CONSCIOUSNESS DISORDER; DIARRHEA; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG TOLERABILITY; FATIGUE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEALTH CARE COST; HUMAN; INSOMNIA; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIVEDO RETICULARIS; MENIERE DISEASE; MULTIPLE SCLEROSIS; NARCOLEPSY; NAUSEA; NERVOUSNESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RATING SCALE; REHABILITATION CARE; REVIEW; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SLEEP APNEA SYNDROME; VASCULITIS; VERTIGO; VOCATION;

DISABILITY EVALUATION; FATIGUE; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; UNITED STATES;

EID: 64749104913     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2008.12.003     Document Type: Review

References (55)

1. Anderson D.W., Ellenberg J.H., Leventhal C.M., et al. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 31 3 (1992) 333-336
2. Hirtz D., Thurman D.J., Gwinn-Hardy K., et al. How common are the "common" neurologic disorders?. Neurology 68 5 (2007) 326-337
3. Kraft G.H., Freal J.E., and Coryell J.K. Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives. Arch Phys Med Rehabil 67 3 (1986) 164-168
4. Krupp L.B., Alvarez L.A., LaRocca N.G., et al. Fatigue in multiple sclerosis. Arch Neurol 45 4 (1988) 435-437
5. Hemmett L., Holmes J., Barnes M., et al. What drives quality of life in multiple sclerosis?. QJM 97 10 (2004) 671-676
6. Chaudhuri A., and Behan P.O. Fatigue in neurological disorders. Lancet 363 9413 (2004) 978-988
7. Giovannoni G. Multiple sclerosis related fatigue. J Neurol Neurosurg Psychiatry 77 1 (2006) 2-3
8. Mills R.J., and Young C.A. A medical definition of fatigue in multiple sclerosis. QJM 101 1 (2008) 49-60
9. Fisk J.D., Pontefract A., Ritvo P.G., et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21 1 (1994) 9-14
10. Hubsky E.P., and Sears J.H. Fatigue in multiple sclerosis: guidelines for nursing care. Rehabil Nurs 17 4 (1992) 176-180
11. Rampello A., Franceschini M., Piepoli M., et al. Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther 87 5 (2007) 545-555 [discussion: 555-549]
12. Rasova K., Brandejsky P., Havrdova E., et al. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?. Mult Scler 11 2 (2005) 213-221
13. van den Berg M., Dawes H., Wade D.T., et al. Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry 77 4 (2006) 531-533
14. Newman M.A., Dawes H., van den Berg M., et al. Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study. Mult Scler 13 1 (2007) 113-119
15. Rasova K., Havrdova E., Brandejsky P., et al. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler 12 2 (2006) 227-234
16. Bourdette D.N., Prochazka A.V., Mitchell W., et al. Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group. Arch Phys Med Rehabil 74 1 (1993) 26-31
17. Whetten-Goldstein K., Sloan F.A., Goldstein L.B., et al. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler 4 5 (1998) 419-425
18. Lapierre Y., and Hum S. Treating fatigue. Int MS J 14 2 (2007) 64-71
19. Packer T.L., Sauriol A., and Brouwer B. Fatigue secondary to chronic illness: postpolio syndrome, chronic fatigue syndrome, and multiple sclerosis. Arch Phys Med Rehabil 75 10 (1994) 1122-1126
20. Egner A., Phillips V.L., Vora R., et al. Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation study. NeuroRehabilitation 18 2 (2003) 125-133
21. Mathiowetz V. Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis. Am J Occup Ther 57 4 (2003) 389-395
22. Kos D., Nagels G., D'Hooghe M.B., et al. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol 6 (2006) 1-8
23. Morris M.E., Cantwell C., Vowels L., et al. Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J Neurol Neurosurg Psychiatry 72 3 (2002) 361-365
24. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 9 3 (2003) 219-227
25. Heesen C., Nawrath L., Reich C., et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. J Neurol Neurosurg Psychiatry 77 1 (2006) 34-39
26. Gottschalk M., Kumpfel T., Flachenecker P., et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 62 2 (2005) 277-280
27. Zwarts M.J., Bleijenberg G., and van Engelen B.G. Clinical neurophysiology of fatigue. Clin Neurophysiol 119 1 (2008) 2-10
28. Roelcke U., Kappos L., Lechner-Scott J., et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48 6 (1997) 1566-1571
29. Marrie R.A., Fisher E., Miller D.M., et al. Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci 228 2 (2005) 161-166
30. Tartaglia M.C., Narayanan S., Francis S.J., et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61 2 (2004) 201-207
31. Bakshi R., Miletich R.S., Henschel K., et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 53 5 (1999) 1151-1153
32. Mainero C., Faroni J., Gasperini C., et al. Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 246 6 (1999) 454-458
33. White A.T., Wilson T.E., Davis S.L., et al. Effect of precooling on physical performance in multiple sclerosis. Mult Scler 6 3 (2000) 176-180
34. Romani A., Bergamaschi R., Candeloro E., et al. Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment. Mult Scler 10 4 (2004) 462-468
35. Schwartz C.E., Coulthard-Morris L., and Zeng Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 77 2 (1996) 165-170
36. Johansson S., Ytterberg C., Gottberg K., et al. Use of health services in people with multiple sclerosis with and without fatigue. Mult Scler 15 (2009) 88-95
37. Ytterberg C., Johansson S., Andersson M., et al. Variations in functioning and disability in multiple sclerosis. A two-year prospective study. J Neurol 255 7 (2008) 967-973
38. Attarian H.P., Brown K.M., Duntley S.P., et al. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 61 4 (2004) 525-528
39. Auger C., Montplaisir J., and Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 65 10 (2005) 1652-1653
40. Ferini-Strambi L., Filippi M., Martinelli V., et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 125 2 (1994) 194-197
41. Leuschen M.P., Filipi M., and Healey K. A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis. Mult Scler 10 6 (2004) 636-642
42. Oken B.S., Kishiyama S., Zajdel D., et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62 11 (2004) 2058-2064
43. Mathiowetz V., Matuska K.M., and Murphy M.E. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil 82 4 (2001) 449-456
44. Tomassini V., Pozzilli C., Onesti E., et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 218 1-2 (2004) 103-108
45. Shug A.L., Schmidt M.J., Golden G.T., et al. The distribution and role of carnitine in the mammalian brain. Life Sci 31 25 (1982) 2869-2874
46. The Canadian MS Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 14 3 (1987) 273-278
47. van Oosten B.W., Truyen L., Barkhof F., et al. Choosing drug therapy for multiple sclerosis. An update. Drugs 56 4 (1998) 555-569
48. Rossini P.M., Pasqualetti P., Pozzilli C., et al. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 7 6 (2001) 354-358
49. Sheean G.L., Murray N.M., Rothwell J.C., et al. An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. Brain 121 Pt 5 (1998) 967-975
50. Lee D., Newell R., Ziegler L., et al. Treatment of fatigue in multiple sclerosis: a systematic review of the literature. Int J Nurs Pract 14 2 (2008) 81-93
51. Wingerchuk D.M., Benarroch E.E., O'Brien P.C., et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology 64 7 (2005) 1267-1269
52. Pozzilli C., Prosperini L., Sbardella E., et al. Interferon after 10 years in patients with multiple sclerosis. Neurol Sci 27 Suppl 5 (2006) S369-S372
53. Rammohan K.W., and Lynn D.J. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 65 12 (2005) 1139-43; author reply 1995-1997
54. Stankoff B., Waubant E., Confavreux C., et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 64 7 (2005) 1139-1143
55. Gillson G., Richard T.L., Smith R.B., et al. A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis. Mult Scler 8 1 (2002) 30-35